What 2024 brought in comprehensive obesity management
Published in:
Forum Diab 2025; 14(1): 3
Category:
Editorial
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
2025 Issue 1
-
All articles in this issue
- What 2024 brought in comprehensive obesity management
- Key insights for comprehensive obesity management in 2024/2025
- Diagnosis, severity assessment and management of obesity
- Effective communication – in obesity treatment crucial for achieving better outcomes
- Obesity, type 2 diabetes and cognitive disorders
- Dietary supplements in weight reduction: efficacy and safety
- Management of obesity and obesity-associated comorbidities in the child and adolescent population
- Využitie genetického rizikového skóre pre diabetes mellitus 1. typu v detskej diabetológii
- Postavenie semaglutidu v liečbe kardio-reno-hepato-metabolického syndrómu
- Semaglutid a progresia periférneho artériového obliterujúceho ochorenia pri diabete 2. typu
- Dapagliflozín v liečbe pacientov s diabetes mellitus 2. typu a nediabetických pacientov so srdcovým zlyhávaním alebo chronickou chorobou obličiek
- Mikronutrienty a nové možnosti liečby vitamínom D v klinickej praxi
- Využitie tirzepatidu v postbariatrickom manažmente u pacientky s gynoidným typom obezity: kazuistika
- Forum Diabetologicum
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Key insights for comprehensive obesity management in 2024/2025
- Diagnosis, severity assessment and management of obesity
- Management of obesity and obesity-associated comorbidities in the child and adolescent population
- Dapagliflozín v liečbe pacientov s diabetes mellitus 2. typu a nediabetických pacientov so srdcovým zlyhávaním alebo chronickou chorobou obličiek